SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-072520
Filing Date
2020-06-11
Accepted
2020-06-11 18:59:25
Documents
2
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1530
2 EX-24 ex-24.htm EX-24 9313
  Complete submission text file 0001104659-20-072520.txt   12196
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38944 | Film No.: 20958381